Close Menu

NEW YORK – Axovant Gene Therapies, a drugmaker focused on neurological diseases, has partnered with genetic testing firm Invitae to launch a free genetic testing and counseling program for children, called Detect Lysosomal Storage Diseases.

The program aims to reduce misdiagnosis and underdiagnosis of lysosomal storage disorders (LSDs) GM1 and GM2 gangliosidosis, otherwise known as Tay-Sachs and Sandhoff disease. Within the program, Invitae will provide free genetic testing on a 53-gene panel and counseling to patients suspected of having an LSD.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.